How does Rosuvastatin impact lipid metabolism in patients with non-alcoholic fatty liver disease, and what role does it play in reducing liver-associated cardiovascular risks?
Sahil KapoorExplorer
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer peopleβs questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Rosuvastatin impact lipid metabolism in patients with non-alcoholic fatty liver disease, and what role does it play in reducing liver-associated cardiovascular risks?
Rosuvastatin improves lipid metabolism by reducing LDL cholesterol and triglycerides while increasing HDL cholesterol, potentially decreasing cardiovascular risks in NAFLD patients.